Skip to main content
Equibles

Patrick Soon-Shiong

Chairman

ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX)

Board Member

ImmunityBio, Inc. (IBRX)

Equibles does not estimate personal net worth.

Get an email with a short summary when ImmunityBio, Inc. publishes a filing, an earnings call transcript or a press release.

Get IBRX alerts

About Patrick Soon-Shiong

Patrick Soon-Shiong is recorded as Chairman and Board Member at ImmunityBio, Inc. (IBRX). The newest filing on record that lists Patrick Soon-Shiong as Board Member at ImmunityBio, Inc. (IBRX) is dated April 30, 2026. The newest filing on record that lists Patrick Soon-Shiong as Chairman at ImmunityBio, Inc. (IBRX) is dated April 29, 2021. The proxy statement of ImmunityBio, Inc. reports total compensation of $12,293,255 for Patrick Soon-Shiong in fiscal 2025, including a base salary of $648,826. Disclosed compensation is on record for 8 fiscal years. Patrick Soon-Shiong has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for ImmunityBio, Inc. on March 10, 2026. ImmunityBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at ImmunityBio, Inc. includes Richard Adcock (CEO and Board Member), David Sachs (CFO and Chief Accounting Officer), Regan Lauer (Chief Accounting Officer) and 7 others.

Patrick Soon-Shiong on recent calls

“When we began the clinical trial of N803 plus BCG back in 2014, we had the inclination that this could be a game changer. The very first patient we enrolled was Alvera.”
Chairman, The Citizens Life Sciences Conference ·
“Welcome, everybody, to our conference call, and it's really a seminal moment for the company where on an annual basis, we provide an update. But this year, it's really very special because not only do we have an approval, we have the commercial results that we can show that's operational excellence on execution.”
Chairman, ImmunityBio, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at ImmunityBio, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 ImmunityBio, Inc. (IBRX) $648,826 $12,293,255
2024 ImmunityBio, Inc. (IBRX) $625,777 $8,220,694
2023 ImmunityBio, Inc. (IBRX) $621,000 $865,340
2022 ImmunityBio, Inc. (IBRX) $616,962 $3,788,251
2021 ImmunityBio, Inc. (IBRX) $237,692 $839,867
2020 ImmunityBio, Inc. (IBRX) $523,477 $644,014
2019 ImmunityBio, Inc. (IBRX) $320,446 $331,646
2018 ImmunityBio, Inc. (IBRX) $638,446 $908,746

Recent activity